Cadila Healthcare gets Mexican regulatory nod to market Lipaglyn drug
Drug firm Cadila Healthcare on Friday said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for the treatment of dyslipidemia in... Clarification sought from Cadila Healthcare Ltd
The Exchange has sought clarification from Cadila Healthcare Ltd with respect to news article appearing on www.livemint.com on November 10, 2017 titled "Zydus Cadila, Intas under scanner for launching hypertension drug without permit".The reply is awaited. Zydus announces regulatory approval of Lipaglyn (Saroglitazar Magnesium) in Mexico
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated November 10, 2017 titled "Zydus announces regulatory approval of Lipaglyn (Saroglitazar Magnesium) in Mexico". Nesher Pharma gets USFDA nod to market ADHD tablets
Cadila Healthcare today said that Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA, has received final approval from the US health regulator to market Dextroamphetamine Sulfate and... Press Release / Media Release
Zydus' Nesher Pharmaceuticals gets USFDA final approval for Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets Analyst / Investor Meet - Intimation
Pursuant to regulation 30 of the SEBI [Listing Obligations and Disclosure Requirements] Regulations, 2015, we hereby inform that the Company has planned investor interaction through a conference call on November 14, 2017 at 4:00 p.m., post announcement of unaudited financial results for the quarter / half year ended on September 30, 2017. Press Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline Hyclate Tablets USP Zydus Cadila gets USFDA nod for skin ointment
Zydus Cadila has received approval from the US health regulator to market Clobetasol Propionate ointment, used to treat a range of skin conditions, in the American market. The company has... Press Release / Media Release
Zydus receives final approval from the USFDA for Clobetasol Propionate Ointment USP Zydus Cadila gets USFDA nod to market breast cancer drug
Drug firm Zydus Cadila today said it has received final approval from the United States Food and Drug Administration (USFDA) to market Tamoxifen Citrate Tablets USP in the strengths of 10 mg (base)...